Concomitant t(8;21) and trisomy 4 in a patient with Acute
Myeloid Leukemia (AML)

QR Code

Concomitant t(8;21) and trisomy 4 in a patient with Acute Myeloid Leukemia (AML)

The t(8;21)(q22;q22) is a frequently occurring aberration in acute myeloid leukemia (AML) (18-20%) and usually correlate with French-America-British (FAB) M2 subtype. Several studies showed that patients carrying this abnormality demonstrated good response to standard chemotherapy but also have a...

Full description

Bibliographic Details
Main Authors:	Phan CL, Ong TC, Chang KM, Zubaidah Z, Puteri Jamilatul NMB
Format:	Article
Language:	English
Published:	Penerbit UKM 2010
Online Access:	http://journalarticle.ukm.my/2079/ http://journalarticle.ukm.my/2079/1/08MS090_4144.pdf

Similar Items

Deciphering S-Phase Protein Kinase 2 (Skp2) Mediated Regulation Of Telomerase Reverse Transcriptase (Tert) In Kasumi-1, T (8;21) Acute Myeloid Leukemia (Aml) Cell Line
by: Rosli, Nur Aliaa Arina
Published: (2023)

Gene Expression Profile And Modulation Of Genetic Pathways In Acute Myeloid Leukaemia T(8;21)
by: Bashanfer, Salem Ali Alsalem
Published: (2013)

Suppression Of Aml1/ETO Via siRNA Mediated Gene Knockdown And Its Effects On FOXO3 AND c-Myc Expression In Aml t (8,21) Cells
by: Ong, Si Min
Published: (2017)

Downregulation Of Skp2 Via siRNA Mediated Gene Knockdown And Its Effects On FOXO3 AND c-MYC Expression In AML t(8,21) Cells
by: Purushodman, Kasturi
Published: (2017)

Imbalanced expression of polycistronic miRNA in acute myeloid leukemia
by: Kotaki, Ryutaro, et al.
Published: (2017)

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
by: Ley, T., et al.
Published: (2013)

Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
by: Laurent, A.P., et al.
Published: (2020)

Clinical evaluation and proteomic profiles of acute myeloid leukemia patients, Saudi Arabia
by: Almaiman, Amer Abdulrahman
Published: (2015)

Generation, Phenotyping and Functional Analysis of Dendritic Cells (DC) Derived from Human Monocytes and Acute Myeloid Leukaemia (AML) Cells
by: Lim, Moon Nian
Published: (2004)

Proteomics profiling and genomics computational analysis of acute myeloid leukemia / Md. Mirazul Islam
by: Md. Mirazul, Islam
Published: (2017)

Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells
by: Alharbi, Raed A., et al.
Published: (2017)

Towards Understanding the Role of Trisomy 21 in Down Syndrome Leukaemia
by: Carey-Smith, Shannon Lee
Published: (2024)

Java based automatic curriculum generator for children with Trisomy 21
by: Supriyanto, Eko, et al.
Published: (2007)

Targeted RNAi of the mitogen-activated protein kinase pathway genes in acute myeloid leukemia cells
by: Mohd Hafiz, M.R., et al.
Published: (2013)

Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy.
by: Abdullah, Maha, et al.
Published: (2009)

Subtractive hybridization identifies stem cell-associated genes in an acute myeloid leukemia with poor prognosis
by: Ngiow, Shin Foong, et al.
Published: (2016)

Eccentricity of Acute Myeloid Leukemia with NPM1 and FLT3-ITD mutation: a case report
by: Nur Zainura Mohamad,, et al.
Published: (2022)

Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy
by: Young, Christine S., et al.
Published: (2017)

Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M,, et al.
Published: (2019)

Targeting dormancy in acute myeloid leukaemia
by: Doolan, Lara
Published: (2023)

Non-invasive prenatal testing: MeDIP-PCR to detect trisomy 21 from maternal plasma
by: Abdul Ghafar, Nurul Fatehah, et al.
Published: (2019)

Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing
by: Maxwell, S., et al.
Published: (2017)

Gene Expression, Biochemical And Functional Analysis Of Stromal Interaction Molecule 1 (Stim1) Silencing In Acute Myeloid Leukemia Cell Lines
by: Algariri, Eman Salem Saeed
Published: (2022)

Flowcytometric analysis of acute leukemia
by: Aziz, Muhammad Zaki Abdul
Published: (2005)

Trisomy X and myelodysplastic syndrome (MDS) with eosinophilia
by: Mohd Tohit, Eusni Rahayu, et al.
Published: (2012)

Analysis of Madm, a novel adaptor protein that associates with Myeloid Leukemia Factor 1
by: Lim, Raelene
Published: (2003)

Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subtypes
by: Smitheman, K.N., et al.
Published: (2019)

Survival analysis in acute myeloid leukemia: A retrospective cohort study and simulation study of small events per independent variable / Law Kian Boon
by: Law , Kian Boon
Published: (2017)

Identifying and targeting dormant cells in acute myeloid leukaemia
by: Yu, N.
Published: (2016)

Less utilized prognostic markers in acute myeloid leukaemia
by: Abdullah, Maha
Published: (2016)

Cytotoxic Effects of Betulinic Acid and its Derivatives on Human Myeloid Leukemia (Hl-60) Cell Line
by: Faujan, Nur Hana
Published: (2008)

Acute kidney injury induced lithium toxicity with concomitant neuroleptic malignant syndrome
by: Lai, Yin Ye, et al.
Published: (2024)

Recent advances in diagnosis of acute myeloid leukaemia : a review.
by: Ambayya, Angeli, et al.
Published: (2013)

Proteomic profile of acute myeloid leukaemia: a review update
by: Almaiman, Amer Abdulrahman, et al.
Published: (2016)

Identification of differentially expressed proteins as biomarkers of acute myeloid leukaemia
by: Barantalab, Fatemeh
Published: (2014)

Selection of reference genes for quantitative studies in acute myeloid leukaemia
by: Lee, Cindee, et al.
Published: (2019)

Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
by: Razali, Ruzi Hamimi
Published: (2015)

Imatinab mesylate treatment in Chronic Myeloid Leukemia (CML)- understanding the fundamental pharmacokinetic and pharmacogenetic mechanisms for variation in response
by: Ankathil, Ravindran
Published: (2016)

Biphenotypic acute leukemia: a report of two cases
by: RZ Azma,, et al.
Published: (2006)

Increased regulatory T cells in acute lymphoblastic leukemia patients
by: Idris, Siti Zuleha, et al.
Published: (2015)